The production utilization rate for 2021, 2022 and 2023 and the six months ended June 30, 2024 was 72.3%, 69.8%, 71.8% and 72.8%, receptively.
Financial Information · p. 375
We plan to increase our production capacity from 12,500 wafers per month as of June 30, 2024 to 70,000 wafers per month over the next five years.
Business · p. 287
Despite the rapid expansion of our production capacity during the Track Record Period, the utilization rate of our production bases continued to improve since we commenced mass production in 2022, reaching 72.8% in the six months ended June 30, 2024.
During this initial ramp-up period, the production volume reached approximately 55,000 units, resulting in a utilization rate of 34.2% for 2022.
Business · p. 264
The production utilization rate at our Bao'an Production Base was relatively low, mainly because most of our solutions delivered in the form of hardware were mainly manufactured by our contract manufacturers during the Track Record Period and we were generally not allowed to change the production sites without relevant customers' consents.
Therefore, we generally reach peak utilization rate of the production capacity in the fourth quarter of the year for such core components.
Business · p. 350
However, in 2023, we reached peak utilization of our production capacity of MEAs in the second quarter of the year because we launched the second production line of MEAs in Shanghai Plant in July 2023, which expansion doubled our production capacity for the third and fourth quarters, and in turn lowered the utilization rates such periods, notwithstanding that the production volumes in the third and fourth quarters were actually higher than the production volume in the second quarter.
Business · p. 350
In addition, we expect to further expand our production capability, which would enable us to ensure product availability, achieve economies of scale, enhance production efficiency and reduce average production cost to alleviate the effects of seasonality.
The lower utilization rate for the six months ended June 30, 2024 primarily resulted from slower sales as our sales volume decreased by approximately 10.4% compared to the six months ended June 30, 2023.
Business · p. 300
For the three months ended September 30, 2024, our utilization rate was 90.8%.
Business · p. 300
The actual volume of gold purified decreased from 13,702 kg in 2021 to 7,577 kg in 2022, and then to 6,270 kg in 2023.
The current capacity of our manufacturing facility enables us to produce 500,000 vials of Utidelone Injection per year.
Business · p. 347
Our utilization rate of the current production line was 5.5% for the year ended December 31, 2022, which reflected the decrease in the sales volume of Utidelone Injection resulting from the COVID-19 pandemic in 2022.
Business · p. 349
Considering the projected sales and the current inventory level, we adjusted our production plan and no vials of Utidelone Injection were produced for the five months ended May 31, 2024.
For FY2021/22, FY2022/23 and FY2023/24, the utilisation rate of our major construction machinery and equipment was 100%, 100% and 100%, respectively.
Business · p. 228
During FY2023/24, we acquired new machinery to supplement the machinery that have short remaining useful life or have been fully depreciated in our fleet of machinery.
Business · p. 228
Our executive Directors consider that continuing and further investments in machinery are necessary in order to cope with our business development and increase our overall operational efficiency and capacity in performing our site works.
The utilization rate declined in 2022, primarily due to the COVID-19 outbreaks and the restrictions imposed in response at the time that affected the supply chain and the market demand for home appliances, which in turn affected our manufacturing volume.
Business · p. 220
The utilization rate increased in 2023 and the four months ended 30 April 2024, mainly due to increased consumer demand for our products, driven by enhanced product
While the entire production process for SR2X Series and Vision Jet aircraft is approximately 51 and 98 days, respectively, in 2021, 2022 and 2023, our average production rate for SR2X series was 10.3, 11.4 and 13.0 aircraft per week, and for Vision Jet 1.8, 1.9 and 2.0 aircraft per week, respectively.
Business · p. 242
Our production capacity (weekly output), actual units produced (average weekly output) and utilization rate for the SR2X Series aircraft for the five months ended May 31, 2024 was 14.0, 10.9 and 78%, respectively, as compared to 14.0, 12.1 and 86%, respectively, for the five months ended May 31, 2023.
Summary · p. 23
We expect that our production capacity will increase by approximately 12 to 60 aircraft per year by the end of 2025 and by 37 to 100 aircraft by the end of 2026 compared to 2023 production levels.
For the year ended 31 December 2023, the utilisation rates of our two self-owned production facilities were approximately 100.9% and 70.1%, respectively.
Summary · p. 2
The utilisation rates of each of our selfowned production facilities was approximately 51.7% and 82.1% for the year ended 31 December 2022, and approximately 70.1% and 100.9% for the year ended 31 December 2023, respectively.
Business · p. 166
Our Directors managed to reduce idle capacity of us during the Track Record Period by establishing relationships with others customers.
For the years ended 31 December 2022 and 2023, the utilisation rates were approximately 52.5% and 40.9% for our precision machining and approximately 78.3% and 118.6% for our precision welding, respectively at our Singapore Factory and the utilisation rates were approximately 46.2% and 48.4%, respectively for our precision machining at our Malaysia Factory.
Business · p. 204
Our production facilities for precision machining were not fully utilised during the Track Record Period, primarily due to limited resources for procurement of raw materials and recruitment of skilled workers to maximise the machine hours in operation.
Business · p. 204
Therefore, our Directors believe that we have spare capacity to serve other existing customers or new customers subject to the availability of working capital and skilled workers.
The utilization rates were 102.4%, 122.8% and 104.0% for our Wuhan Production Plant, and 91.8%, 91.7% and 86.4% for our Qianjiang Xinyihong Production Plant for the years ended December 31, 2021, 2022 and 2023.
Financial Information · p. 259
In anticipation of the industry trends and our business growth in the larger organic synthetic chemical products industry, and to better serve our clients in the PRC and the global market, we have undertaken efforts to expand our current production capacity.
This lump-sum and all-or-nothing basis of charging requires our Group to allocate and schedule the traffic flow in order to avoid idling capacity.
Summary · p. 1
Thus, we may run the risk of idling bandwidth capacity if our clients’ demand falls short of our fixed capacity.
Business · p. 194
In order to improve bandwidth utilisation efficiency for the purpose of reducing our Group’s overall cost, we installed a sophisticated traffic-scheduling equipment in the fourth quarter of 2021, which has improved our packet port bandwidth utilisation rate.
The fill rate of LCD screen increased from approximately 17% in 2022 to approximately 27% in 2023, reflecting the improved economic efficiency and operational capacity of our vending machines.
Business · p. 278
The redundancy rates of our vending machines in 2021, 2022, and 2023 were approximately 14.0%, 14.2%, and 14.7%, respectively.
Due to the lower average yearly temperature, the cultivation conditions of our Dalian Facility are slightly inferior as compared to other facilities, resulting in a relatively lower utilisation rate during the Track Record Period.
Business · p. 216
The lower utilisation rate of our cultivation facilities in FY2022 was primarily due to the resurgence of COVID-19 cases which affected our business operations.
Business · p. 216
In addition, for the 9M2023, the utilisation rate of our Laixi Facility, Xi’an Facility and Dalian Facility was approximately 91.3%, 68.8% and 58.5%, respectively, while the overall utilisation rate of our three cultivation facilities is approximately 88.1%, which has returned to the FY2020 and FY2021 level.
With production of 15 batches in 2023, the utilization rate of our Taizhou Manufacturing Facility was 37.5%, including the manufacturing of our own drug candidates under development (11 batches, or 27.5% of our manufacturing capacity), the commercial scale production of QX001S (2 batches, or 5.0% of our manufacturing capacity) and CDMO services provided to Zhongmei Huadong (2 batches, or 5.0% of our manufacturing capacity) pursuant to relevant service contract.
Business · p. 365
Additionally, we have successfully developed a new drug substance upstream process, which starts a production run with high cell-density and large volume working cell bank, and therefore could significantly shorten the production time required for each batch, improve capacity utilization and lower unit manufacturing costs.
Business · p. 365
With the utilization rate of our manufacturing facility for 2023 at 37.5% (taking into account the manufacturing of our own drug candidates under development, the commercial scale production of QX001S and CDMO services provided to Zhongmei Huadong pursuant to relevant service contract), we are able to provide CDMO services to external parties as a measure to improve the utilization rate of our spare manufacturing capacity on the premise of ensuring the production plans of our own products.
The utilisation rate of the Dapianmei Production Facility decreased from approximately 96.8% in FY2020 to 80.1% in FY2021; whilst the utilisation rate of the Xinlong Production Facility decreased from approximately 85.3% in FY2020 to 76.2% in FY2021.
Business · p. 194
As the available workspace at our Xinlong Production Facility is shared between the production and storage functions, the actual production volume of the facility has been affected by the volume and size of materials and finished products placed therein from time to time.
Business · p. 193
Having considered the fabrication works for Project No. #12 and #13, it is expected that the utilisation rates of our production facilities will be relatively higher during the fourth quarter of 2023.
The decrease in the number of tenders submitted and successful tenders from FY2020 to FY2021 and the decrease in tender success rate in FY2021 for our software development services were mainly attributable to that our Group did not have sufficient capacity to take up more projects at the time, as we had secured a number of projects through non-tender methods for FY2020 and FY2021 and we were constrained from bidding for more tenders for FY2021.
Our Honghualing factory has a monthly designed production capacity of approximately 46,800 units, with a utilization rate of approximately 24.8% in June 2023.
Business · p. 209
We are still in the ramp up period of our production and expect to increase our utilization rate in the future for potential incoming orders.
Business · p. 209
For example, the utilization rate of our Honghualing factory improved from 24.8% in June 2023 to 67.1% in October 2023.
During this period, the utilisation rate of our ore processing plant fell by approximately 28.6% to approximately 51.7% in FY2021 as compared to approximately 80.3% in FY2020.
Summary · p. 15
The utilisation rate of our ore processing plant increased from approximately 51.7% in FY2021 to 100.6% in FY2022, as we operated in the ordinary and usual circumstances in absence of the Temporary Operation Suspension such as that affected our operations in FY2021.
Business · p. 193
We expect to maintain maximum utilisation rate of 100% when we complete the additional construction of mining infrastructure in accordance with our mine optimisation plan at our Songjiagou Open-Pit Mine by expanding the mining surface area by about 150 metres south of its boundaries, as further elaborated in the paragraph headed ‘‘Business strategies — Further construction of mining infrastructure in accordance with our mine optimisation plan’’ in this section.
The utilisation rate of our in-house LNG production is high, we will therefore procure LNG from third-party suppliers when the demand exceeds the supply of LNG produced in-house or when the price spread is considered favourable to us.
Business · p. 227
The sales volume of our products was primarily capped by our production capacity during the Track Record Period.
Financial Information · p. 339
Upon commencement of commercial operation in October 2023, the total production capacity has been doubled from our production capacity per annum since 2020 and reached a total of 400,000 tonnes (measured in terms of the processing capacity of crude benzene) per annum.